Innovative Cellular Therapeutics Holdings Ltd

SEC Form 4 insider trading activity

Innovative Cellular Therapeutics Holdings Ltd has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jul 28, 2026.

Companies traded

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$274

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LYELSale$137Jul 20SEC ↗
LYELSale$137Jul 18SEC ↗